Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer-Reference-Cited by-同舟云学术

Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer

Published:2017-02-21 Issue:1 Volume:163 Page:103-110
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Zetterlund Linda Holmstrand^ORCID,Frisell Jan,Zouzos Athanasios,Axelsson Rimma,Hatschek Thomas,de Boniface Jana,Celebioglu Fuat

Funder

Swedish County Council (ALF project)

Swedish Breast Cancer Association (BRO)

Stiftelsen Olle Engkvist Byggmästare

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-017-4164-1.pdf

Reference32 articles.

1. Giuliano AE, Dale PS, Turner PR, Morton DL, Evans SW, Krasne DL (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222(3):394–399 discussion 9-401

2. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98(9):599–609

3. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–933

4. Bedrosian I, Reynolds C, Mick R, Callans LS, Grant CS, Donohue JH et al (2000) Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 88(11):2540–2545

5. Chung MH, Ye W, Giuliano AE (2001) Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol 8(9):688–692

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study;Breast Cancer Research and Treatment;2024-05-04

2. This house believes that: MARI/TAD is better than sentinel node biopsy after PST for cN+ patients;The Breast;2023-10

3. Sentinel Node Biopsy in Patients With Breast Carcinoma Without Axillary Involvement at Diagnosis Receiving Primary Systemic Therapy;Clinical Breast Cancer;2023-08

4. Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study;Annals of Surgical Oncology;2023-07-03

5. Real de-escalation or escalation in disguise?;The Breast;2023-06